lynestrenol has been researched along with Arterial Occlusive Diseases in 2 studies
Lynestrenol: A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roncaglioni, MC | 2 |
| di Minno, G | 2 |
| Pangrazzi, J | 1 |
| Reyers, I | 2 |
| Mussoni, L | 1 |
| de Gaetano, G | 2 |
| Donati, MB | 2 |
2 other studies available for lynestrenol and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Plasmatic and vascular factors of the hemostatic system in rats receiving an estrogen-progestogen combination.
Topics: Animals; Antithrombin III; Aorta; Arterial Occlusive Diseases; Arteries; Blood Pressure; Epoprosteno | 1980 |
Increased prostacyclin-like activity in vascular tissues from rats on long-term treatment with an oestrogen-progestagen combination.
Topics: Animals; Aorta, Abdominal; Arterial Occlusive Diseases; Blood Vessels; Contraceptives, Oral, Combine | 1979 |